DNA twopointo, INC. (ATUM) has "evaluation license and materials: cell line development expression vector optimization" needed by niaid's vaccine research center. Ambis #2075993

Ended Purchase Order Awarded Last action

Contract number
75N93021P01384
Awardee
Awarding agency
Obligated
$68,095

Award facts

Opportunity
Contract value 100% obligated
$68,094.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Newark, CA 94560, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 -$85
Supplemental Agreement for work within scope P00001 $0
Original award $68,180

Quick answers

Who was awarded contract 75N93021P01384?

75N93021P01384 was awarded to DNA Twopointo Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 20, 2021.

How much is contract 75N93021P01384 worth?

The government has obligated $68,095 on 75N93021P01384.

Was contract 75N93021P01384 competed?

The extent of competition for 75N93021P01384 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login